🕵️ Editas Medicine, Inc. ($EDIT)
SEC insider & ownership activity, last 12 months · CIK 1650664 · every row links its SEC filing
Over the last 12 months insiders sold $107K with no open-market buying against it. O'Neill Gilmore Neil sold $80K through a 10b5-1 trading plan in 4 lots (Dec–Sep). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $107K (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| O'Neill Gilmore Neil | 0 | – | 4 | $80K | Sep 3, 2026 |
| Burkly Linda | 0 | – | 5 | $20K | Sep 3, 2026 |
| Parison Amy | 0 | – | 5 | $6K | Sep 3, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Commodore Capital LP | 9.9% | 13G | Jun 2, 2026 | filing ↗ | |
| Commodore Capital Master LP | 9.9% | 13G | Jun 2, 2026 | filing ↗ | |
| Robert Egen Atkinson | 9.9% | 13G | Jun 2, 2026 | filing ↗ | |
| Michael Kramarz | 9.9% | 13G | Jun 2, 2026 | filing ↗ | |
| TCG Crossover GP III, LLC | 9.9% | 13G | Jun 3, 2026 | filing ↗ | |
| TCG Crossover Fund III, L.P. | 9.9% | 13G | Jun 3, 2026 | filing ↗ | |
| Chen Yu | 9.9% | 13G | Jun 3, 2026 | filing ↗ | |
| RA Capital Management, L.P. | 5.8% | 13G | Jun 3, 2026 | filing ↗ | |
| Peter Kolchinsky | 5.8% | 13G | Jun 3, 2026 | filing ↗ | |
| Rajeev Shah | 5.8% | 13G | Jun 3, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 5.8% | 13G | Jun 3, 2026 | filing ↗ | |
| ADAR1 Capital Management, LLC | 5.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Daniel Schneeberger | 5.8% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| O'Neill Gilmore Neil | $17K | Sep 3, 2026 | filing ↗ |
| Burkly Linda | $2K | Sep 3, 2026 | filing ↗ |
| Burkly Linda | $16K | Jul 27, 2026 | filing ↗ |
| O'Neill Gilmore Neil | $46K | Jun 3, 2026 | filing ↗ |
| O'Neill Gilmore Neil | $11K | Mar 3, 2026 | filing ↗ |
| O'Neill Gilmore Neil | $18K | Dec 3, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | May 26, 2026 | filing ↗ |
| Other events (8.01) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Other events (8.01) | May 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 25, 2026 | filing ↗ |
| Other events (8.01) | May 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Other events (8.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Auditor change (4.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 26, 2026 | filing ↗ |
| Other events (8.01) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Earnings (2.02) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 9, 2025 | filing ↗ |
| Other events (8.01) | Oct 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 9, 2025 | filing ↗ |